Abstract
Summary: Glutaric acidaemia type I (GA I) is caused by the deficiency of glutaryl-CoA dehydrogenase, resulting in accumulation of glutaric acid (GA) and 3- hydroxyglutaric acid (3-OH-GA) in blood and cerebrospinal fluid (CSF). Neuropathological changes with onset in childhood consist of severe neuronal loss in the caudate and putamen. An animal model is necessary to test possible intervention strategies, and prior reports suggested that GA or 3-OH-GA could be used to create specific neuron loss in adult rats. Adult, 3-week-old and 2-week-old rats received intrastriatal injections of GA and 3-OH-GA at a range of doses. High concentrations caused necrotic lesions in striatum. Low concentrations caused white-matter axonal damage and small areas of neuron loss. Injection of lipopolysaccharide prior to administration of 3-OH-GA was not associated with enhanced neuronal loss. Our findings contradict prior claims and we conclude that the simple model of a single GA or 3-OH-GA injection into rat brain does not replicate the neuropathological findings in humans.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
REFERENCES
de Mello CF, Kölker S, Ahlemeyer B, et al (2001)Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res 916:70-75.
Goldman SA, Pulsinelli WA, Clarke WY, Kraig RP, Plum F (1989)The effects of extracellular acidosis on neurons and glia in vitro. JCerebBoodFowMetab 9:471-477.
Goodman SI, Kohlhoü JG (1975)Glutaric aciduria:inherited de ficiency of glutaryl-CoA dehydrogenase activity. Biochem Med 13:138-140.
Goodman SI, Norenberg MD, Shikes RH, Breslich DJ, Moe PG (1977)Glutaric aciduria: biochemical and morphologic considerations. JPediatr 90:746-750.
Hoffmann GF, Meier-Augenstein W, Stockler S, Surtees R, Rating D, Nyhan WL (1993)Physiology and pathophysiology of organic acids in cerebrospinalfluid. JInheritMetabDis 16: 648-669.
Kimura S, Hara M, Nezu A, Osaka H, Yamazaki S, Saitoh K (1994)Two cases of glutaric aciduria type1:clinical and neuropathological findings. J NeurolSci 123:38-43.
Koeller DM, Woontner M, Crnic LS, et al (2002)Biochemical, pathologic and behavioral analysis of a mouse model of glutaric acidemia type I. Hum Mo Genet 11:347-357.
Kölker S, Hoffmann GF, Schor DS, et al (2003)Glutaryl-CoA dehydrogenase deficiency: region-specific analysis of organic acids and acylcarnitines in post mortem brain predicts vulnerability of the putamen. Neuropediatrics 34:253-260.
Kölker S, Koeller DM, Okun JG, Hoffmann GF (2004)Pathomechanisms of neurodegeneration in glutaryl-CoA dehydrogenase deficiency. Ann Neurol 55:7-12.
Lima TT, Begnini J, de Bastiani J, et al (1998)Pharmacological evidence for GABAergic and glutamatergic involvement in the convulsant and behavioral effects of glutaric acid. Brain Res 802:55-60.
Monyer H, Burnashev N, Laurie DJ, Sakmann B, Seeburg PH (1994)Developmental and regional expression in the rat brain and functional properties of four NMDA receptors. Neuron 12:529-540.
Schmued LC, Hopkins KJ (2000)Fluoro-Jade:novelfluorochromes for detecting toxicant induced neuronal degeneration. Toxico Patho 28:91-99.
Siesjo BK, Katsura KI, Kristian T, Li PA, Siesjo P (1996)Molecular mechanisms of acidosis-mediated damage. Acta Neurochir Suppl (Wien )66:8-14.
Soffer D, Amir N, Elpeleg ON, Gomori JM, Shalev RS, Gottschalk-Sabag S (1992)Striatal degeneration and spongy myelinopathy in glutaric acidemia. J Neuro Sci 107:199-204.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Funk, C.B.R., Prasad, A.N. & Bigio, M.R.D. Preliminary attempts to establish a rat model of striatal injury in glutaric acidaemia type I. J Inherit Metab Dis 27, 819–824 (2004). https://doi.org/10.1023/B:BOLI.0000045764.14721.b6
Issue Date:
DOI: https://doi.org/10.1023/B:BOLI.0000045764.14721.b6